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1 Vanderbilt University, Division of Allergy, Pulmonary and Critical Care Medicine, Nashville, TN, 2 Brigham and Women's Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA, 3 Harvard Medical School, Boston, MA. RATIONALE: Aspirin-exacerbated respiratory disease (AERD), a triad of late-onset asthma, chronic rhinosinusitis with nasal polyposis and respiratory reactions to inhibitors of cyclooxygenase-1, disproportionately affects females. Impairments in prostaglandin (PG)E 2, a known regulator of leukotriene (LT) production and mast cell activation, are implicated in the pathobiology of AERD. METHODS: Self-reported clinical characteristics from subjects with AERD enrolled in the Brigham and Women's Hospital AERD patient registry were stratified by sex. A subset of patients underwent an oral aspirin challenge protocol with nasal fluid eicosanoids determined by UPLC-MS. Nasal fluid tryptase was monitored. RESULTS: In 386 subjects with AERD, females (57.3%) reported asthma (P<.0001), nasal polyps (P<.0001), and NSAID-induced respiratory reaction (P<.0001) development earlier in life and were more likely to have been hospitalized for asthma (P<.0001) than males. During aspirin challenge, nasal fluid (n)PGE 2 declined at respiratory reaction onset in females (n512, -2.1760.89 pmol/mL, P5.04), but not in males (n57, 0.2961.13 pmol/mL), with a trend toward greater suppression over the 3-hour reaction period (P5.11). The change in nPGE 2 at reaction onset inversely correlated with nasal fluid tryptase 1 hour later (r p 5-.848, P5.001) and nasal symptoms at onset (r p 5-.541, P5.08) in females but not in males. Females demonstrated a greater increase in nLTC 4 (P5.06) which correlated with the change in nasal symptoms (r p 5.863, P<.001) 1 hour after reaction onset. CONCLUSIONS: Sex differences in PGE 2 -dependent regulation of mast cell function in the respiratory tract may account for the greater prevalence, earlier age of onset, and increased morbidity in females with AERD. Department of Surgery, Brigham and Women's Hospital, Boston, MA. RATIONALE: Mast Cells (MCs) are tissue resident effector cells that play key pathogenic roles in type 2 inflammatory diseases through the generation and release of histamine, proteases, eicosanoids, and cytokines. Although both parenchymal and intraepithelial MCs expand in number in human airway diseases, including asthma and nasal polyposis, the mechanisms driving the expansion of these subsets and the relationship between them remains unclear. METHODS: 7,052 MCs were isolated flow cytometrically from the nasal polyps of 6 individual patients and profiled using the SeqWell platform for massively parallel single cell RNA sequencing (scRNAseq). Relationships between identified MC subsets were inferred using Diffusion Pseudotime Mapping. Expression of cell surface markers and intracellular factors distinguishing MC subsets were further validated through flow cytometric analysis and sorting followed by protease immunostaining. RESULTS: We identified three populations of MCs within nasal polyps, characterized by distinct expression of surface receptors, proteases and inflammatory mediators, including a previously unappreciated subset of proliferating MCs. We established flow cytometric criteria for distinguishing between parenchymal and intraepithelial MCs, and further propose a shared origin for these two mature MC subsets from a recruited progenitor population. CONCLUSIONS: Our findings provide novel insight into the mechanisms underlying MC hyperplasia during type 2 inflammation and the relationship between the recruited progenitors, proliferating MCs, and mature parenchymal and epithelial MC subsets found in type 2 inflammatory settings.
